New Drugs for Obesity Are Entering the Therapeutic Arsenal for Fatty Liver as Well
9 Articles
9 Articles
Injectable therapies open up new perspectives for specific categories of patients, while diet, exercise and weight loss remain the cornerstones of treatment.
ΑΘΗΝΑ 9,84
New obesity drugs are now gaining a place in the treatment of fatty liver, expanding the therapeutic possibilities for a disease that often progresses silently. Injectable therapies open up new prospects for specific categories of patients, while diet, exercise and weight loss remain the cornerstones of treatment, notes the professor of Pathology […]
Askanews
Palermo, 16 Oct. (askanews) - The evolution of the therapeutic treatment of obesity has been at the center of "SIO WiP " Obesity Work in Progress " , the National Congress of the Italian Society of Obesity that took place in Palermo where the highest Italian experts compared themselves on the new scientific frontiers in the treatment of this pathology. Just on the margin [...]
According to the OPTIC survey, presented at the SIO WiP Congress in Palermo, more than 70% of patients with obesity or overweight would prefer oral therapy than injection. Waited in Italy for the beginning of 2027 for semaglutide in weight management pills, approved by AIFA and published in the Official Journal. While for orforglipron the times are still to be defined, but has just arrived the approval EMA. The post Obesity. Over 7 of 10 patient…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
